1
NSUH NSUH NSUH NSUH NSUH NSUH
1 Tyrosine Tyrosine TH [ 18 F] FDOPA DOPA DDC Amphetamine - - PDF document
NSUH NSUH NSUH NSUH NSUH NSUH 1 Tyrosine Tyrosine TH [ 18 F] FDOPA DOPA DDC Amphetamine Reserpin DA Tetrabenazine DAT [ 18 F] FPCIT DOPAC DA [ 123 I] CIT, FPCIT HVA [ 11 C] cocaine, d-threo-methylphenidate D2 D1 NSUH NSUH
1
NSUH NSUH NSUH NSUH NSUH NSUH
2
NSUH NSUH
Tyrosine
Tyrosine
Amphetamine Reserpin Tetrabenazine
DA DOPA TH DDC
DOPAC HVA DA [18F] FDOPA [18F] FPCIT [123I] βCIT, FPCIT [11C] cocaine, d-threo-methylphenidate
DAT
D1 D2
NSUH
Normal Mild Moderate Severe
[18F] FPCIT/PET
NSUH
18F-FPCIT Binding Reductions in PD
H&Y Stage I
NSUH
Figure 8 Eidelberg D
Normal Fetal mesencephalic cell implant FDOPA / PET Postop. Preop. Postop. Preop. Sham surgery
NSUH
5 4 3 2 1
Fetal Dopamine Cell Transplant FDOPA/PET: SPM Analysis (p<0.001)
3
NSUH
18F-FDG 18F-FPCIT
Parkinson’s Disease H&Y I
NSUH
Pons Cerebellum Th PU / GP PMC
PD-related Metabolic Network: Voxel Analysis
(z = -30mm) (z = 54mm) (y = -10mm)
PreSMA Posterior Parietal
1.5 2.0 2.5 3.0 1.0 1.5 2.0 2.5PC1 (20.7% VAF) from analysis of 20 PD and 20 Controls
NSUH
Network Activity Discriminates PD and Controls
10 20 30 40
Subject Score (PDRP)
PD Normal
p < 0.0001
NSUH
10 20 30
OFF ON
PDRP SCORE
Levodopa Infusion
*
* p = 0.01
NSUH
PARKINSON’S DISEASE
PUTAMEN GPL GPM STN SNR BC PPN VA-VL
NSUH
preoperative 1 yr postop 2 yr postop
Implantation: Two year Follow-up
4
NSUH NSUH NSUH NSUH NSUH
MRI-PET Fusion Image Pallidotomy
NSUH
18 F-FDG/PET
63 yrs man rt. pallidotomy
Pre Post
14.0 mg/100g/min
5
NSUH
Task Subtractions
52 mm 40 mm
8 mm
p<0.001
SMA Sensorimotor Thalamus Dentate Vermis preSMA PMC Superior Parietal Lateral cerebellum
NSUH
Effect of GPi stimulation on motor task
0 mm
52 mm 72 mm Threshold p=0.01 (within motor activation mask)
Activation ON > Activation OFF
SMA Motor Putamen Med Cerebellum
NSUH NSUH
SNr VA / VL DN GPi PPN DN
Effect on Brain Glucose Metabolism
(p < 0.001)
NSUH NSUH
6
NSUH